[HTML] sciencedirect.com

[HTML][HTML] A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures

Y Hu, AY Liu, L Zhang, X Wu, S Shi, JR Elmore… - Journal of Vascular …, 2019 - Elsevier
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to
unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …
被引用次数：10 相关文章

A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures.

Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of Vascular …, 2019 - europepmc.org
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to
unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …
[HTML] jvascsurg.org

[HTML][HTML] A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures

Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of Vascular …, 2019 - jvascsurg.org
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to
unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …

A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures

Y Hu, AY Liu, L Zhang, X Wu, S Shi… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective The direct thrombin inhibitor bivalirudin (BIV) was shown to be superior to
unfractionated heparin (UFH) in percutaneous coronary interventions for reducing …